Omnicell, Inc. (OMCL): Price and Financial Metrics
Omnicell, Inc. (OMCL)
Today's Latest Price: $86.55 USD
Updated Oct 30 4:00pm
Add OMCL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
OMCL Stock Summary
- OMCL's current price/earnings ratio is 75.4, which is higher than 89.9% of US stocks with positive earnings.
- With a year-over-year growth in debt of -64.57%, OMNICELL Inc's debt growth rate surpasses merely 3.81% of about US stocks.
- In terms of volatility of its share price, OMCL is more volatile than merely 12.93% of stocks we're observing.
- Stocks that are quantitatively similar to OMCL, based on their financial statements, market capitalization, and price volatility, are TWOU, IRTC, ATRC, VCYT, and QTRX.
- Visit OMCL's SEC page to see the company's official filings. To visit the company's web site, go to www.omnicell.com.
OMCL Stock Price Chart Interactive Chart >
OMCL Price/Volume Stats
| Current price | $86.55 | 52-week high | $94.85 |
| Prev. close | $88.75 | 52-week low | $54.24 |
| Day low | $85.85 | Volume | 492,900 |
| Day high | $89.34 | Avg. volume | 352,675 |
| 50-day MA | $75.55 | Dividend yield | N/A |
| 200-day MA | $72.81 | Market Cap | 3.70B |
Omnicell, Inc. (OMCL) Company Bio
Omnicell provides automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. The company was founded in 1992 and is based in Mountain View, California.
OMCL Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $86.55 | $40.64 | -53% |
We started the process of determining a valid price forecast for OMNICELL Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that OMNICELL Inc ranked in the 28th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for OMCL, they are:
- The company's balance sheet shows it gets 99% of its capital from equity, and 1% of its capital from debt. Its equity weight surpasses that of 89.31% of free cash flow generating stocks in the Technology sector.
- The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately just 6.27% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- OMCL's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 51.19% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -54% |
| 1% | -53% |
| 2% | -53% |
| 3% | -52% |
| 4% | -52% |
| 5% | -51% |
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as OMCL, try INOD, BLKB, MIME, NXPI, and CCMP.
Loading social stream, please wait...